<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00567736</url>
  </required_header>
  <id_info>
    <org_study_id>DISCI-07</org_study_id>
    <secondary_id>EudraCT-Nr. 2006-006390-24</secondary_id>
    <nct_id>NCT00567736</nct_id>
  </id_info>
  <brief_title>Efficacy of Disci/Rhus Toxicodendron Comp.®, in Patients With Chronic Low Back Pain</brief_title>
  <acronym>DISCI</acronym>
  <official_title>Prospective Randomized Controlled Multicentre Trial for Patients With Chronic Low Back Pain Comparing Disci/Rhus Toxicodendron Comp.®, Placebo and Waiting List Group</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>WALA Heilmittel GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the efficacy of Disci/Rhus toxicodendron. comp.® in&#xD;
      patients with chronic low back pain compared to waiting list group, or placebo.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic low back pain is a significant health problem in industrialized countries. Use of&#xD;
      complementary medicine is increasing in patients with low back pain. Until now there is no&#xD;
      evidence for the efficacy of Disci/Rhus toxicodendron. comp.® in patients with chronic low&#xD;
      back pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue scale (0-100 mm) low back pain</measure>
    <time_frame>once after 8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Back function (back function scale FFbHR)</measure>
    <time_frame>once at week 8 and 26</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale (0-100 mm) low back pain</measure>
    <time_frame>once after week 26</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days with medication</measure>
    <time_frame>week 4 to 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life (SF-36)</measure>
    <time_frame>once at week 8 and 26</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain disability scale (PDI)</measure>
    <time_frame>once at week 8 and 26</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>emotional pain scale (SES)</measure>
    <time_frame>once at week 8 and 26</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>influence of patient expectancy</measure>
    <time_frame>once at week 8 and 26</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>influence of physician expectancy</measure>
    <time_frame>once at week 8 and 26</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Responder rate 36% VAS pain intensity</measure>
    <time_frame>once at week 8 and 26</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>numbers of days with absence from work</measure>
    <time_frame>between week 4 and 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days with physician visits because of low back pain</measure>
    <time_frame>between week 4 and 8</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Disci/Rhus toxicodendron comp.®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>waiting list group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Disci/Rhus toxicodendron comp.®</intervention_name>
    <description>s.c. application 10 ml (1 ampul) in 5 to 10 parts on different back pain sites verum group 12 treatments: 8 in the first 4 weeks and 4 in the next 4 weeks</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo solution</intervention_name>
    <description>s.c. application 10 ml (1 ampul) in 5 to 10 parts on different back pain sites 12 treatments: 8 in the first 4 weeks and 4 in the next 4 weeks</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female patients, 30 to 75 years&#xD;
&#xD;
          -  Willingness of following the study protocol&#xD;
&#xD;
          -  Clinical diagnosis of chronic low back pain&#xD;
&#xD;
          -  Low back pain since at least 3 months&#xD;
&#xD;
          -  Average pain intensity of at least 40 mm on VAS (0-100 mm) in the last 7 days&#xD;
&#xD;
          -  In the last 4 weeks only oral NSAD and muscle relaxation treatment&#xD;
&#xD;
          -  Effective oral contraception in woman&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous treatment with DISCI comp.&#xD;
&#xD;
          -  Treatment with other than NSAID&#xD;
&#xD;
          -  Routine use of pain drugs for other diseases&#xD;
&#xD;
          -  Protrusio or prolapse of one or more intervertebral discs with neurological symptoms&#xD;
&#xD;
          -  Previous spine surgery&#xD;
&#xD;
          -  (Suspicious) infectious spondylopathy&#xD;
&#xD;
          -  Low back pain because of malignant or infectious disease&#xD;
&#xD;
          -  Other causes of back pain symptoms (e.g. M. Bechterev, M. Reiter)&#xD;
&#xD;
          -  Congenital deformity of spine (without minor lordosis or kyphosis or scoliosis&#xD;
&#xD;
          -  (Suspicious) osteoporosis with compression fracture&#xD;
&#xD;
          -  (Suspicious) spinal stenosis&#xD;
&#xD;
          -  Spondylolysis or spondylolisthesis&#xD;
&#xD;
          -  Physiotherapy in the last four weeks or planed during trial&#xD;
&#xD;
          -  Begin of a new treatment for low back pain&#xD;
&#xD;
          -  Complementary treatment in the last four weeks or planed during trial&#xD;
&#xD;
          -  Patients who are not able to cooperate in a sufficient way&#xD;
&#xD;
          -  Patients with alcohol or substance abuse&#xD;
&#xD;
          -  Participation in another clinical trial&#xD;
&#xD;
          -  Severe chronical or acute disease which does not allow study participation&#xD;
&#xD;
          -  Patients with bleeding disorders or oral anticoagulation treatment&#xD;
&#xD;
          -  Pregnancy and breast feeding&#xD;
&#xD;
          -  Patients with application for pension&#xD;
&#xD;
          -  Patients involved in planning or coordination of the study&#xD;
&#xD;
          -  Hypersensitivity against drug components&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia M Witt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>o Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Pach D, Brinkhaus B, Roll S, Wegscheider K, Icke K, Willich SN, Witt CM. Efficacy of injections with Disci/Rhus toxicodendron compositum for chronic low back pain--a randomized placebo-controlled trial. PLoS One. 2011;6(11):e26166. doi: 10.1371/journal.pone.0026166. Epub 2011 Nov 8.</citation>
    <PMID>22087222</PMID>
  </results_reference>
  <verification_date>August 2009</verification_date>
  <study_first_submitted>December 4, 2007</study_first_submitted>
  <study_first_submitted_qc>December 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2007</study_first_posted>
  <last_update_submitted>July 10, 2012</last_update_submitted>
  <last_update_submitted_qc>July 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2012</last_update_posted>
  <responsible_party>
    <name_title>Institute for Social Medicine, Epidemiology, and Health Economics</name_title>
    <organization>Charité University Medical Center Berlin</organization>
  </responsible_party>
  <keyword>low back pain</keyword>
  <keyword>complementary therapies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

